Medicare Enrolled

Dr. Janki Trivedi, M.D.

Rheumatology · Sun City, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
29798 HAUN RD, Sun City, CA 92586
9516721866
In practice since 2010 (16 years)
NPI: 1356665905 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Trivedi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Trivedi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Trivedi

Dr. Janki Trivedi is a rheumatology specialist in Sun City, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Trivedi performed 16,098 Medicare services across 794 unique beneficiaries.

Between the years covered by Open Payments, Dr. Trivedi received a total of $20,544 from 38 pharmaceutical and/or device companies across 1021 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Trivedi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 20% volume in CA $20,544 industry payments

Medicare Practice Summary

Medicare Utilization ↗
16,098
Medicare services
Top 20% in CA for rheumatology
794
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,006 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
7,775 $34 $150
Denosumab injection (Prolia/Xgeva) 4,260 $18 $50
Rituximab injection, 10 mg
Administration of a 10 mg dose of rituximab medication via injection.
1,803 $63 $250
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
731 $98 $195
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
656 $1 $5
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
174 $54 $150
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
110 $24 $110
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
101 $12 $55
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
95 $55 $179
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
65 $7 $150
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
56 $137 $241
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
53 $111 $385
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
52 $118 $241
Trigger point injection, 1-2 muscles
A procedure involving the injection of medication into one or two specific muscles to treat trigger points.
42 $38 $171
Tendon or ligament injection
A procedure involving the injection of medication into a tendon or ligament.
26 $40 $140
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
22 $31 $100
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
22 $13 $55
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
22 $74 $146
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
19 $4 $55
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
14 $33 $105
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
49.7% high complexity
44.9% medium
5.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$20,544
Total received (2018-2024)
Avg $2,935/year across 7 years
Top 17% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
1,021
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,913 (87.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,630 (12.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,663
2023
$3,754
2022
$2,958
2021
$988
2020
$628
2019
$3,857
2018
$4,695

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$951
Amgen Inc.
$854
Novartis Pharmaceuticals Corporation
$484
UCB, Inc.
$313
GlaxoSmithKline, LLC.
$238
ANI Pharmaceuticals, Inc.
$220
Boehringer Ingelheim Pharmaceuticals, Inc.
$106
Janssen Biotech, Inc.
$89
AstraZeneca Pharmaceuticals LP
$87
Radius Health, Inc.
$67
Aurinia Pharma U.S., Inc.
$47
Lilly USA, LLC
$45
E.R. Squibb & Sons, L.L.C.
$43
PFIZER INC.
$39
Genentech USA, Inc.
$33
SOBI, INC
$30
SCILEX PHARMACEUTICALS INC.
$18
Top 3 companies account for 62.5% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$3,994
Amgen Inc.
$2,525
Novartis Pharmaceuticals Corporation
$1,793
ABBVIE INC.
$1,656
AbbVie Inc.
$1,397
PFIZER INC.
$1,317
GlaxoSmithKline, LLC.
$1,301
AbbVie, Inc.
$1,117
Horizon Therapeutics plc
$715
Janssen Biotech, Inc.
$713
Lilly USA, LLC
$483
AstraZeneca Pharmaceuticals LP
$458
E.R. Squibb & Sons, L.L.C.
$431
Celgene Corporation
$340
Genentech USA, Inc.
$331
Aurinia Pharma U.S., Inc.
$296
ANI Pharmaceuticals, Inc.
$220
Boehringer Ingelheim Pharmaceuticals, Inc.
$212
GENZYME CORPORATION
$160
Janssen Scientific Affairs, LLC
$129
Mallinckrodt Enterprises LLC
$119
Alexion Pharmaceuticals, Inc.
$107
Antares Pharma, Inc.
$99
Radius Health, Inc.
$93
MEDEXUS PHARMA, INC.
$82
Cumberland Pharmaceuticals, Inc.
$74
Horizon Pharma plc
$71
Sobi, Inc
$63
SOBI, INC
$51
SANOFI-AVENTIS U.S. LLC
$44
Mallinckrodt Hospital Products Inc.
$37
Organon LLC
$25
CSL Behring
$18
SCILEX PHARMACEUTICALS INC.
$18
ARBOR PHARMACEUTICALS, INC.
$17
Kiniksa Pharmaceuticals, Ltd.
$13
MEDAC PHARMA, INC.
$13
Ferring Pharmaceuticals Inc.
$11
Top 3 companies account for 40.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · EUFLEXXA · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · Hizentra · Horizant · Humira · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · OFEV · ORENCIA · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · REDITREX · REMICADE · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · XELJANZ · XYOSTED · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Sun City?
Compare rheumatologists in the Sun City area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
29
Per 100K population
1.2
County median income
$89,672
Nearest hospital
MENIFEE GLOBAL MEDICAL CENTER
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Trivedi is a mixed practice specialist, with above-average Medicare volume (top 20% in CA), with low-engagement industry engagement in the top 17% of CA peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Trivedi experienced with abatacept infusion (orencia)?
Based on Medicare claims data, Dr. Trivedi performed 7,775 abatacept infusion (orencia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Trivedi receive payments from pharmaceutical companies?
Yes. Dr. Trivedi received a total of $20,544 from 38 companies across 1,021 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Trivedi's costs compare to other rheumatologists in Sun City?
Dr. Trivedi's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Trivedi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →